| Literature DB >> 36234927 |
Solanki Bal1, Amit Baran Sharangi2, Tarun Kumar Upadhyay3, Fahad Khan4, Pratibha Pandey4,5, Samra Siddiqui6, Mohd Saeed7, Hae-Jeung Lee8, Dharmendra K Yadav9.
Abstract
Worldwide, since ages and nowadays, traditional medicine is well known, owing to its biodiversity, which immensely contributed to the advancement and development of complementary and alternative medicines. There is a wide range of spices, herbs, and trees known for their medicinal uses. Chilli peppers, a vegetable cum spice crop, are bestowed with natural bioactive compounds, flavonoids, capsaicinoids, phytochemicals, phytonutrients, and pharmacologically active compounds with potential health benefits. Such compounds manifest their functionality over solo-treatment by operating in synergy and consortium. Co-action of these compounds and nutrients make them potentially effective against coagulation, obesity, diabetes, inflammation, dreadful diseases, such as cancer, and microbial diseases, alongside having good anti-oxidants with scavenging ability to free radicals and oxygen. In recent times, capsaicinoids especially capsaicin can ameliorate important viral diseases, such as SARS-CoV-2. In addition, capsaicin provides an ability to chilli peppers to ramify as topical agents in pain-relief and also benefitting man as a potential effective anesthetic agent. Such phytochemicals involved not only make them useful and a much economical substitute to wonder/artificial drugs but can be exploited as obscene drugs for the production of novel stuffs. The responsibility of the TRPV1 receptor in association with capsaicin in mitigating chronic diseases has also been justified in this study. Nonetheless, medicinal studies pertaining to consumption of chilli peppers are limited and demand confirmation of the findings from animal studies. In this artifact, an effort has been made to address in an accessible format the nutritional and biomedical perspectives of chilli pepper, which could precisely upgrade and enrich our pharmaceutical industries towards human well-being.Entities:
Keywords: Capsicum annuum; TRPV1 receptor; anticancer properties; antioxidants; capsaicin; capsaicinoids; health benefits
Mesh:
Substances:
Year: 2022 PMID: 36234927 PMCID: PMC9570844 DOI: 10.3390/molecules27196380
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Nutritional contents of chilli fruits across species (per 100 g of edible portion).
| Nutrients | Peppers, Hot | Peppers, Sweet, Green (Raw) {b} | Spices, Pepper, Red or Cayenne {c} | References |
|---|---|---|---|---|
| Carbohydrate (g) | 9.46 | 4.64 | 56.63 | [ |
| Protein (g) | 2.00 | 0.86 | 12.01 | [ |
| Fat (g) | 0.20 | 0.17 | 17.27 | [ |
| Energy (kcal) | 40 | 20 | 318 | [ |
| Iron (mg) | 1.20 | 0.34 | 7.80 | [ |
| Calcium (mg) | 18 | 10 | 148 | [ |
| Sodium (mg) | 7 | 3 | 30 | [ |
| Potassium (mg) | 340 | 175 | 2014 | [ |
| Phosphorus (mg) | 46 | 20 | 293 | [ |
| Copper (mg) | 0.30 | 0.066 | 0.373 | [ |
| Selenium (μg) | 0.5 | 0.0 | 8.8 | [ |
{a}—Botanically: C. frutescens. {b}—Botanically: C. annuum. {c}—Botanically: C. frutescens or C. annuum.
Figure 1Bioactive compounds present in chilli, their structure and therapeutic applications.
Figure 2A model pathway depicting biosynthesis of Capsaicin.
Figure 3Effect of capsaicin on TRPV1 receptor [53,54,55].
Figure 4Bioactivity of CAPS attributed to Vanillyl group present in the structure [65,66].
Figure 5Interaction of CAPS and VR-1 [65,66].
Inhibition effects of capsaicinoids on diversified cells satirizing the antitumor activity.
| Type of Cancer | Diversified Cell Lines | Inhibitory Effects | References |
|---|---|---|---|
| Pancreatic cancer | BxPC-3 and AsPC-1 (pancreatic cancer) | Inhibitory effects by generation of ROS resulting in induction of apoptosis | [ |
| Blood leukemia | Human myelocytic leukemia (HL-60) | Inhibitory effects by induction of autophagy by caspase-3-dependent process | [ |
| Human KB cancer | KB (which is derived from HeLa cell line) | Inhibitory effects by staggering cell cycle at G2/M phase causing inducing apoptosis | [ |
| Tongue cancer | Squamous-Cell Carcinoma (SCC-4) | Inhibitory effects by mitochondria dependent and independent mechanisms causing induction of apoptosis | [ |
| Lung cancer | NCI-H69, NCI-H82 | Inhibitory effects by arresting cell cycle at GI | [ |
| Nasopharyngeal cancer | Nasopharyngeal Carcinoma (NPC-TW 039) in human | Inhibitory effects by mitochondrial alteration and stress in endoplasmic reticulum causing induction of apoptosis | [ |
| Hepatic cancer | HepG2 (human hepatoma) | Inhibitory effects by disruption of ROS causing induction of apoptosis | [ |